Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachida Bouamar

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|June 8, 2013
Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimusRamin Vafadari, Rachida Bouamar, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|March 9, 2011
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantationRachida Bouamar, Dennis A Hesselink, Ron H N van Schaik, et al.
Therapeutic Drug Monitoring|July 25, 2025
Tacrolimus Exposure is Associated with Acute Rejection in the Early Phase After Kidney Transplantation: A Joint Modeling ApproachMaaike R Schagen, Alvaro Assis de Souza, Karin Boer, et al.
Pharmacogenetics and Genomics|September 1, 2011
Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipientsRachida Bouamar, Dennis A Hesselink, Ron H N van Schaik, et al.
Transplantation Direct|April 1, 2017
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseLouise M Andrews, Brenda C M de Winter, Jiang-Tao Tang, et al.
Clinical Transplantation|March 4, 2014
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patientsZhigang Chen, Rachida Bouamar, Ron H N Van Schaik, et al.
Therapeutic Drug Monitoring|September 25, 2013
Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patientsLaure Elens, Dennis A Hesselink, Rachida Bouamar, et al.
BMJ Open|December 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trialNadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Chemistry|September 10, 2011
A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|June 8, 2013
Genetic polymorphisms in ABCB1 influence the pharmacodynamics of tacrolimusRamin Vafadari, Rachida Bouamar, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|March 9, 2011
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are not associated with cyclosporine pharmacokinetics nor with cyclosporine clinical end points after renal transplantationRachida Bouamar, Dennis A Hesselink, Ron H N van Schaik, et al.
Therapeutic Drug Monitoring|July 25, 2025
Tacrolimus Exposure is Associated with Acute Rejection in the Early Phase After Kidney Transplantation: A Joint Modeling ApproachMaaike R Schagen, Alvaro Assis de Souza, Karin Boer, et al.
Pharmacogenetics and Genomics|September 1, 2011
Mycophenolic acid-related diarrhea is not associated with polymorphisms in SLCO1B nor with ABCB1 in renal transplant recipientsRachida Bouamar, Dennis A Hesselink, Ron H N van Schaik, et al.
Transplantation Direct|April 1, 2017
Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting DoseLouise M Andrews, Brenda C M de Winter, Jiang-Tao Tang, et al.
Clinical Transplantation|March 4, 2014
Genetic polymorphisms in IL-2, IL-10, TGF-β1, and IL-2RB and acute rejection in renal transplant patientsZhigang Chen, Rachida Bouamar, Ron H N Van Schaik, et al.
Therapeutic Drug Monitoring|September 25, 2013
Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patientsLaure Elens, Dennis A Hesselink, Rachida Bouamar, et al.
BMJ Open|December 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trialNadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen, et al.
Pageof 2